Bausch Health Companies Inc.
General ticker "BHC" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.4B (TTM average)
Bausch Health Companies Inc. follows the US Stock Market performance with the rate: 26.5%.
Estimated limits based on current volatility of 3.0%: low 6.95$, high 7.39$
Factors to consider:
- Total employees count: 20700 as of 2024
- Top business risk factors: BL separation risks, Litigation risks, Economic downturns and volatility, Regulatory and compliance, Reputation and brand risks
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.79$, 11.35$]
- 2025-12-31 to 2026-12-31 estimated range: [5.23$, 10.49$]
Financial Metrics affecting the BHC estimates:
- Positive: with PPE of 2.0 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 16.49
- Positive: Operating cash flow per share per price, % of 57.22 > 13.24
- Negative: negative Industry operating cash flow (median)
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of -0.27
- Negative: Shareholder equity ratio, % of -4.82 <= 18.93
- Negative: negative Industry operating income (median)
- Negative: -0.75 < Inventory ratio change, % of -0.49
Short-term BHC quotes
Long-term BHC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $8,089.00MM | $8,729.00MM | $9,378.00MM |
| Operating Expenses | $7,635.00MM | $7,766.00MM | $7,832.00MM |
| Operating Income | $454.00MM | $963.00MM | $1,546.00MM |
| Non-Operating Income | $-583.00MM | $-1,353.00MM | $-1,379.00MM |
| Interest Expense | $1,464.00MM | $1,328.00MM | $1,388.00MM |
| R&D Expense | $529.00MM | $604.00MM | $616.00MM |
| Income(Loss) | $-129.00MM | $-390.00MM | $167.00MM |
| Taxes | $83.00MM | $221.00MM | $239.00MM |
| Profit(Loss)* | $-225.00MM | $-592.00MM | $-46.00MM |
| Stockholders Equity | $-692.00MM | $-1,022.00MM | $-1,279.00MM |
| Inventory | $1,090.00MM | $1,544.00MM | $1,595.00MM |
| Assets | $25,686.00MM | $27,350.00MM | $26,523.00MM |
| Operating Cash Flow | $-728.00MM | $1,032.00MM | $1,597.00MM |
| Capital expenditure | $268.00MM | $272.00MM | $337.00MM |
| Investing Cash Flow | $-303.00MM | $-2,145.00MM | $-454.00MM |
| Financing Cash Flow | $-474.00MM | $1,475.00MM | $-868.00MM |
| Earnings Per Share** | $-0.62 | $-1.62 | $-0.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.